PMA device
Rx Heculink Elite Renal Stent System
Abbott Vascular · Stent, Renal (NIN, Class III) · First FDA decision Jun 26, 2012, newest Jun 26, 2012High blood pressure (hypertension)Peripheral artery disease
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
0
Naming "Rx Heculink Elite"
MAUDE reports
0
Brand "Rx Heculink Elite", since 2015
PubMed studies
0
Mentioning "Rx Heculink Elite"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Rx Heculink Elite Renal Stent System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 1 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Percutaneous Transluminal Angioplasty (PTA) and Stenting of the Renal ArteriesNational analysisReview closedCAG-00085R4Updated Sep 21, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Rx Heculink Elite", any status and sponsor, newest update first.
No registered device study names "Rx Heculink Elite".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Rx Heculink Elite", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NIN
665 reports: 292 malfunction, 345 injury, 26 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Rx Heculink Elite"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code NIN.
- Formula Balloon-Expandable Renal Stent SystemCook Medical Incorporated · PMA 2014
- Express Sd Renal Monorail Premounted Stent SystemBoston Scientific Corp · PMA 2016
- Rx Herculink Elite Renal Stent SystemAbbott Vascular · PMA 2014
- Express SD Monorail Premounted Stent SystemBoston Scientific Corp · PMA 2020
- Boston Scientific Express Sd Renal Monorail Premounted Stent SystemBoston Scientific Corp · PMA 2008
- Cordis Palmaz Balloon Expandable StentsCordis US Corporation · PMA 2003
- Medtronic Ave Bridge Extra Support Over-The-Wire Renal Stent SystemMedtronic Vascular · PMA 2003
- Palmaz Balloon-Expandable StentCordis US Corporation · PMA 2002
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.